Liberalized vs Neutropenic Diet Phase III Trial: Nutritional Intake

Pirtobrutinib Versus Ibrutinib

Liberalized vs Neutropenic Diet Phase III Trial: Key Result

HS Explained: Your Questions, A Dermatologists Answers

Liberalized vs Neutropenic Diet Phase III Trial: Trial Design

Withdrawal of Tazemetostat

Tissue Issues: A Deep Dive into Cutaneous Connective Tissue Disease

TRIPLETE Study: PFS Results

TRIPLETE Study: Key Takeaways

MALS

TRIPLETE Study: ORR Results

TRIPLETE Study: Patient Population

TRIPLETE Study: Overview

Most People Don't Know Constipation

Neoantigen-Specific TIL in GI Cancers: The Future

Laxatives are Physical Therapy

Lasers, Scabies & Dupixent Dilemmas

ORIGIN-3 Summary

Neoantigen-Specific TIL in GI Cancers: Prognostic Factors

Probiotic and Low FODMAP

Neoantigen-Specific TIL in GI Cancers: Results

Zongertinib Receives FDA Approval

Neoantigen-Specific TIL in GI Cancers: Patient Population

IBS-Mental Health Genomics

Neoantigen-Specific TIL in GI Cancers: What is TIL Therapy?

OPBC-07/microNAC: Clinical Implications

OPBC-07/microNAC: Key Findings

OPBC-07/microNAC: Study Profile

OPBC-07/microNAC: Primary Objective

SunRISe-4: Safety Profile & Next Steps

OPBC-07/microNAC: Standard Treatment and the Shift Toward Surgical De-Escalation

AV in CLL

SGLT2i & CKD/HF

SunRISe-4: Recurrence-Free Survival

EyeCan Season 6, Episode 6 - When the Body Says Nothing - the Story Behind the Biomaterial Comprising the PRESERFLO® MicroShunt Used to Treat Glaucoma with guest Dr. Leonard Pinchuk

Chapter Nineteen: Metabolic Acidosis, part 3

SunRISe-4: Trial Overview

IDeate-Lung01: Brain Metastases & CNS Control

ASPREE Follow-Up: Clinical Takeaways

IDeate-Lung01: Rapid Responses & Durability

ASPREE Follow-Up: Mechanistic Hypotheses

ASPREE Follow-Up: Melanoma Outlier

Discussing ISM/MCAS: Dr. Kuykendall

IBS Behavioural Therapies: Key Takeaways

IBS Behavioural Therapies: Quality of Review

ASPREE Follow-Up: Signal by Cancer Stage

IBS Behavioural Therapies: Long-Term Efficacy Gaps

IBS Behavioural Therapies: Gut Pain Regulation

ASPREE Follow-Up: Cancer Incidence Outcomes

IBS Behavioural Therapies: Minimal Contact Disease Self Management

Discussing MCAS: Dr. Hamilton

TTF Approved in Pancreatic Cancer

sFlt1/PIGF to Detect Pre-eclampsia

Beta Blockers in HFrEF and CKD

Paradoxic Albuminuria ARNI

Your Skin Their Canvas: What You Need to Know About Tattoos

Residual Disease

Dual HER2 Blockade

Time-of-Day Immunochemotherapy: Randomized Phase 3 Trial

Germline BRCA